These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16556138)

  • 21. Treatment of ectopic calcification in uremia.
    Zucchelli P; Fusaroli M; Fabbri L; Pavlica P; Casanova S; Viglietta G; Sasdelli M
    Kidney Int Suppl; 1978 Jun; (8):S86-90. PubMed ID: 99599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis.
    Ilter E; Karalok H; Tufekci EC; Batur O
    Climacteric; 2006 Apr; 9(2):129-34. PubMed ID: 16698659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: Osteomalacia due to bisphosphonate treatment in a patient on hemodialysis.
    Hatano M; Kitajima I; Yamamoto S; Nakamura M; Isawa K; Hirota Y; Hoshino J; Sawa N; Ubara Y
    BMC Nephrol; 2021 Sep; 22(1):298. PubMed ID: 34479496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calciphylaxis in POEMS syndrome: A case treated with etidronate.
    Yoshikawa M; Uhara H; Arakura F; Murata H; Kubo H; Takata M; Yoshida K; Okuyama R
    Acta Derm Venereol; 2011 Jan; 91(1):98-9. PubMed ID: 20927488
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
    J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.
    Goeree R; Blackhouse G; Adachi J
    Curr Med Res Opin; 2006 Jul; 22(7):1425-36. PubMed ID: 16834841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
    Kranenburg G; de Jong PA; Bartstra JW; Lagerweij SJ; Lam MG; Ossewaarde-van Norel J; Risseeuw S; van Leeuwen R; Imhof SM; Verhaar HJ; de Vries JJ; Slart RHJA; Luurtsema G; den Harder AM; Visseren FLJ; Mali WP; Spiering W
    J Am Coll Cardiol; 2018 Mar; 71(10):1117-1126. PubMed ID: 29519353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of blue rubber bleb nevus syndrome treated by etidronate.
    Kishikawa H; Okada Y; Kawahara T; Saito K; Tanaka Y
    J Bone Miner Metab; 2007; 25(2):138-41. PubMed ID: 17323184
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiallodynic effect of etidronate, a bisphosphonate, in rats with adjuvant-induced arthritis: involvement of ATP-sensitive K+ channels.
    Kawabata A; Kawao N; Hironaka Y; Ishiki T; Matsunami M; Sekiguchi F
    Neuropharmacology; 2006 Aug; 51(2):182-90. PubMed ID: 16678221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of Risedronate by biochemical bone markers in clinical practice.
    Bunyaratavej N
    J Med Assoc Thai; 2005 Oct; 88(suppl 5):S34-6. PubMed ID: 17500121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
    Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
    Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weekly risedronate in kidney transplant patients with osteopenia.
    Torregrosa JV; Fuster D; Pedroso S; Diekmann F; Campistol JM; Rubí S; Oppenheimer F
    Transpl Int; 2007 Aug; 20(8):708-11. PubMed ID: 17555530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
    Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
    J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of statin treatment on aortic valve and coronary artery calcification.
    Mohler ER; Wang H; Medenilla E; Scott C
    J Heart Valve Dis; 2007 Jul; 16(4):378-86. PubMed ID: 17702362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thirty-month follow-up of coronary artery calcification in hemodialysis patients: different roles for inflammation and abnormal calcium-phosphorous metabolism?
    Patsalas S; Eleftheriadis T; Spaia S; Theodoroglou H; Antoniadi G; Liakopoulos V; Passadakis P; Vayonas G; Vargemezis V
    Ren Fail; 2007; 29(5):623-9. PubMed ID: 17654327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beneficial effect of high-dose etidronate on periarticular calcinosis associated with arterial and periarticular basic calcium phosphate (BCP) crystal deposition disease].
    Ito G; Suzuki Y; Uehara R; Ide M; Ozaki S
    Ryumachi; 2003 Oct; 43(4):644-8. PubMed ID: 14598656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.